Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Patterns of Statin Use in Older Medicare Beneficiaries With Traumatic Brain Injury.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Khokhar B, Simoni-Wastila L, Slejko JF, Perfetto E, Zhan M, Smith GS.
PMID: 29577114
J Pharm Technol. 2017;33(4):156-166. doi: 10.1177/8755122517710671. Epub 2017 May 23.

BACKGROUND: In addition to lowering lipids, statins also may be beneficial for older adults sustaining a traumatic brain injury (TBI), as statin use prior to and following trauma may decrease mortality following injury. However, despite statins' potential to reduce...

Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort study.

Drug and alcohol dependence

Olopoenia A, Camelo-Castillo W, Qato DM, Adekoya A, Palumbo F, Sera L, Simoni-Wastila L.
PMID: 34847506
Drug Alcohol Depend. 2021 Nov 17;230:109180. doi: 10.1016/j.drugalcdep.2021.109180. Epub 2021 Nov 17.

BACKGROUND: Our goal was to describe specific patterns associated with co-prescriptions of gabapentin, opioids, and benzodiazepines among disabled Medicare beneficiaries.METHODS: Using 2013-2015 Medicare data, we conducted a retrospective cohort study among fee-for-service disabled beneficiaries continuously enrolled in Medicare Parts...

Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort study.

Drug and alcohol dependence

Olopoenia A, Camelo-Castillo W, Qato DM, Adekoya A, Palumbo F, Sera L, Simoni-Wastila L.
PMID: 34847506
Drug Alcohol Depend. 2021 Nov 17;230:109180. doi: 10.1016/j.drugalcdep.2021.109180. Epub 2021 Nov 17.

BACKGROUND: Our goal was to describe specific patterns associated with co-prescriptions of gabapentin, opioids, and benzodiazepines among disabled Medicare beneficiaries.METHODS: Using 2013-2015 Medicare data, we conducted a retrospective cohort study among fee-for-service disabled beneficiaries continuously enrolled in Medicare Parts...

In-Hospital Mortality Following Traumatic Brain Injury Among Older Medicare Beneficiaries, Comparing Statin Users With Nonusers.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Khokhar B, Simoni-Wastila L, Slejko JF, Perfetto E, Zhan M, Smith GS.
PMID: 29607441
J Pharm Technol. 2017 Dec;33(6):225-236. doi: 10.1177/8755122517735656. Epub 2017 Oct 12.

BACKGROUND: Traumatic brain injury (TBI) is a significant public health concern for older adults. Small-scale human studies have suggested pre-TBI statin use is associated with decreased in-hospital mortality following TBI, highlighting the need for large-scale translational research.OBJECTIVE: To investigate...

2018 American Society of Consultant Pharmacists Annual Meeting & Exhibition.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists

Bridgeman M, Prete D, Rolston N, Abazia D, Sturgill M, Finn L, Summers D, Marvanova M, Henkel P, Thompson J, Dewey M, Friesner D, Marvanova M, Alessi C, Cuellar L, Yamagishi L, O'Neil C, Erickson O, Mazzei K, Kamal K, Early N, Bainter B, Hanson L, Schmitz E, Loomis A, Norberto M, Hume A, Meyer M, Batra R, Likar D, Enguidanos S, Liu C, Kotansky B, Fisher A, Ruby CM, Pruskowski J, Karim SNA, Yong BSW, Alessi C, Cuellar L, Slattum P, Crouse E, Delafuente J, Donohoe K, Ogbonna K, Peron E, Powers K, Price E, Zimmerman K, Rahim S, Gendron T, Slattum P, Donohoe K, Cho C, Zimmerman K, Crouse E, Peron E, Powers K, Price E, Slattum P, Donohoe K, Elliott L, Minter C, Morin M, Marshall L, Stevens G, Cordaro C, Hill M, Nagy K, Kroustos KR, Sobota KF, Mahan R, Bailey T, Ioannou K, Mansour D, Thompson T, Chatellier K, Schwenk A, Ruby C, Chen TS, Li S, James M, Spilios M, Leschak A, Levine A, Forgette S, Oluigbo N, Szollosi D, Avalime D, Weaver SB, Maneno M, Ettienne E, Yi JY, Hart L, Gray S, Ozalas S, Miller K, Dave R, Bork J, Emmelhainz J, Adams K, Postolski J, Willoughby M, Feldman E, Braham K, Miller C, Barbagallo D, Seabury R, Noviasky J, Alessi C, Cuellar L, Dabhi J, Bartlett D, Le T, Simoni-Wastila L, Kuzucan A, Simoni-Wastila L, Le T, Park S, Simoni-Wastila L, Le T, Park S, Choi M, Simoni-Wastila L, Park S, Le T, Choi M, Simoni-Wastila L, Khokhar B, Choi M, Le T, Simoni-Wastila L, Brody P, Hejna M, Mason J, Graham M, Micceri J, Lypska R, Quinn B, Wilson H, Wahler R, Aloyo M, Tomm V, Hill A, Obringer A, Butterfoss K, Blak J, Balcer R, Boza J, Foster A, Shafique E, Kleven C, Wigle P, Brown B, Alessi C, Cuellar L, Meyer K, Mobley-Bukstein W, Singh H, Perez E, Mira AE, Kuehner W, Czechowski L, Cook H, Brandt N, Parson J, Fornaro R, Brandt N, Claeys K, Zarowitz B, Mansour D, McFadden C, Simpkins S, Ojowa F, Klutts A, Holmes S, Smith E, Cornman JR, Doran K, Resnick B, Brandt N, Umeozulu C, Williams A, Brandt N, Hennawi G, Thomas D, Gerber DK, Meyer K, Sharma K, Cooke C, Howard A, Chater R, Vogler A, Brandt N, Kennett-Hayes K, Elliott L, Engelbert J, Hargrave E, Bambico C, Patel K, Warriner C, Slattum P, Desai NR, Rowan CG, Alvarez P, Fogli J, Toto RD, Desai NR, Alvarez P, Fogli J, Reed P, Owens MK, Greden JF, Rothschild AJ, Zandy S, Thase M, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Li J, Gilbert A, Burns L, Jablonski M, Dechairo B, Parikh S, Donohue J, Feldman G, Sethi S, Barnes C, Pendyala S, Bourdet D, Ferguson G, Barnes C, Pendyala S, Crater G, Fogli J, Mayo M, Gross C, Miyawa J, Ono R, Woods S, Garza D, Panov N, Fogli J, Moran E, Sabesan V, Wertman J, Ngim K.
PMID: 30322434
Consult Pharm. 2017 Oct 01;33(10):572-608.

Poster abstracts are evaluated based on the following criteria: significance of the problem to healthy aging or medication management; innovativeness of ideas, methods, and/or approach; methodological rigor of methods and approach; presentation of finding; implications identified for future research,...

Prevalence and Newly Diagnosed Rates of Multimorbidity in Older Medicare Beneficiaries with COPD.

COPD

Le TT, Qato DM, Magder L, Bjarnadóttir M, Zafari Z, Simoni-Wastila L.
PMID: 34468243
COPD. 2021 Oct;18(5):541-548. doi: 10.1080/15412555.2021.1968815. Epub 2021 Sep 01.

Few studies have quantified the multimorbidity burden in older adults with chronic obstructive pulmonary disease (COPD) using large and generalizable data. Such evidence is essential to inform evidence-based research, clinical care, and resource allocation. This retrospective cohort study used...

Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort study.

Drug and alcohol dependence

Olopoenia A, Camelo-Castillo W, Qato DM, Adekoya A, Palumbo F, Sera L, Simoni-Wastila L.
PMID: 34847506
Drug Alcohol Depend. 2022 Jan 01;230:109180. doi: 10.1016/j.drugalcdep.2021.109180. Epub 2021 Nov 17.

BACKGROUND: Our goal was to describe specific patterns associated with co-prescriptions of gabapentin, opioids, and benzodiazepines among disabled Medicare beneficiaries.METHODS: Using 2013-2015 Medicare data, we conducted a retrospective cohort study among fee-for-service disabled beneficiaries continuously enrolled in Medicare Parts...

Query mandates in prescription drug monitoring programs reduce opioid use among commercially insured patients with cancer.

Journal of the American Pharmacists Association : JAPhA

Le TT, Fleming SP, Kuzucan A, Dizik A, Simoni-Wastila L.
PMID: 34246576
J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):363-369. doi: 10.1016/j.japh.2021.06.013. Epub 2021 Jun 15.

BACKGROUND: Prescription drug monitoring programs (PDMPs) have been shown to reduce opioid use in the general and noncancer populations. However, evidence of PDMP impacts on patients with cancer remains limited.OBJECTIVE: The aim of the study was to examine the...

Query mandates in prescription drug monitoring programs reduce opioid use among commercially insured patients with cancer.

Journal of the American Pharmacists Association : JAPhA

Le TT, Fleming SP, Kuzucan A, Dizik A, Simoni-Wastila L.
PMID: 34246576
J Am Pharm Assoc (2003). 2021 Jun 15; doi: 10.1016/j.japh.2021.06.013. Epub 2021 Jun 15.

BACKGROUND: Prescription drug monitoring programs (PDMPs) have been shown to reduce opioid use in the general and noncancer populations. However, evidence of PDMP impacts on patients with cancer remains limited.OBJECTIVE: The aim of the study was to examine the...

Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort study.

Drug and alcohol dependence

Olopoenia A, Camelo-Castillo W, Qato DM, Adekoya A, Palumbo F, Sera L, Simoni-Wastila L.
PMID: 34847506
Drug Alcohol Depend. 2021 Nov 17;230:109180. doi: 10.1016/j.drugalcdep.2021.109180. Epub 2021 Nov 17.

BACKGROUND: Our goal was to describe specific patterns associated with co-prescriptions of gabapentin, opioids, and benzodiazepines among disabled Medicare beneficiaries.METHODS: Using 2013-2015 Medicare data, we conducted a retrospective cohort study among fee-for-service disabled beneficiaries continuously enrolled in Medicare Parts...

Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

Cardiology research and practice

Blanchette CM, Simoni-Wastila L, Shaya FT, Orwig D, Noel J, Stuart B.
PMID: 20069046
Cardiol Res Pract. 2009;2009:194528. doi: 10.4061/2009/194528. Epub 2009 Dec 22.

Purpose. Depression and antidepressant use may independently increase the risk of acute myocardial infarction and mortality in adults. However, no studies have looked at the effect of depression on a broader thrombotic event outcome, assessed antidepressant use, or evaluated...

Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort study.

Drug and alcohol dependence

Olopoenia A, Camelo-Castillo W, Qato DM, Adekoya A, Palumbo F, Sera L, Simoni-Wastila L.
PMID: 34847506
Drug Alcohol Depend. 2021 Nov 17;230:109180. doi: 10.1016/j.drugalcdep.2021.109180. Epub 2021 Nov 17.

BACKGROUND: Our goal was to describe specific patterns associated with co-prescriptions of gabapentin, opioids, and benzodiazepines among disabled Medicare beneficiaries.METHODS: Using 2013-2015 Medicare data, we conducted a retrospective cohort study among fee-for-service disabled beneficiaries continuously enrolled in Medicare Parts...

Showing 1 to 12 of 16 entries